Results 161 to 170 of about 968,734 (398)

The rise of companies from emerging markets in global health governance: opportunities and challenges [PDF]

, 2014
The article analyses the involvement of pharmaceutical companies from emerging markets in global health governance. It finds that they play a central role as low-cost suppliers of medicines and vaccines and, increasingly, new technologies.
ANNE ROEMER-MAHLER, Brooks, Brown, Buse, Chaudhuri, Clarke, Cooper Ramo, Drezner, Elbe, Fleury, Gold, Knight, Levy, Meyer, Petryna, Ramamurti, Roemer-Mahler, Schoofs, Wells, Whyte, Williams, Williamson, Youde, Zimmerman   +23 more
core   +1 more source

Influenza vaccination in Korea

Journal of Infection, 2014
open
Jae Kwan Jun, Eun Cheol Park, Han Na Shin, Kwang Sig Lee   +3 more
openaire   +4 more sources

Intravenous iRGD‐Guided, RBC‐Membrane Camouflaged Lactococcus Lactis Remodels Cold NSCLC and Enhances PD‐1 Blockade

Advanced Science, EarlyView.
This study presents an engineered probiotic platform, iRGD‐mRBC@FOLactis, combining red blood cell membrane cloaking and tumor‐penetrating peptide iRGD for enhanced PD‐1 blockade. The platform improves tumor targeting, immune cell activation and therapeutic efficacy in lung cancer, demonstrating significant promise in overcoming PD‐1/PD‐L1 therapy ...
Chen Chen, Junmeng Zhu, Xiao Liu, Jie Shao, Aoxing Chen, Yi Mei, Xinyin Zhang, Qinyi Chen, Lin Li, Baorui Liu   +9 more
wiley   +1 more source

Fighting flu: novel CD8+ T‐cell targets are required for future influenza vaccines

Clinical & Translational Immunology
Seasonal influenza viruses continue to cause severe medical and financial complications annually. Although there are many licenced influenza vaccines, there are billions of cases of influenza infection every year, resulting in the death of over half a ...
Samuel Liwei Leong, Stephanie Gras, Emma J Grant   +2 more
doaj   +1 more source

Concentration and Purification of Influenza Virus for the Preparation of Vaccines [PDF]

, 1945
A. R. Taylor, D. G. Sharp, I. W. McLean, Dorothy Beard, J. W. Beard   +4 more
openalex   +1 more source

The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines?

Human Vaccines & Immunotherapeutics, 2018
The search for a test that can predict vaccine efficacy is an important part of any vaccine development program. Although regulators hesitate to acknowledge any test as a true ‘correlate of protection’, there are many precedents for defining ‘surrogate ...
B. Ward, S. Pillet, N. Charland, S. Trépanier, Julie Couillard, N. Landry   +5 more
semanticscholar   +1 more source

An Aptamer‐Based EXACT Anticoagulant as a Sustainable, Animal‐Free Alternative to Unfractionated Heparin

Advanced Science, EarlyView.
By simply conjugating thrombin's active‐site inhibitor, dabigatran, with an exosite inhibitor, aptamer HD1, the resulting EXosite‐ACTive site (EXACT) inhibitors show two orders of magnitude higher potency and selectivity via synergistic binding, while maintaining the aptamer's antidote‐reversible trait, yielding a potential substitute for the animal ...
Haixiang Yu, George Pitoc, Manqi Zhang, Jeffrey Clancy, James Frederiksen, Amy Yan, Samuel Francis, Rebecca Sullenger, Rachel Rempel, Susannah Gammell, Jillian Caiazzi, Bruce A. Sullenger   +11 more
wiley   +1 more source

Maintaining the value of influenza vaccination – the shift from quadrivalent to trivalent vaccines: an expert review

Expert Review of Vaccines
Introduction This review provides an expert perspective on the sustained value of seasonal influenza vaccines as they transition from quadrivalent to trivalent formulations, based on apparent elimination of the B/Yamagata strain from circulation and ...
David Fisman, Alberto Pérez-Rubio, Maarten Postma, Darvin S. Smith, Joaquin Mould-Quevedo   +4 more
doaj   +1 more source

The Effect of Low Temperatures on Vaccines of Influenza Virus and on Purified Influenza Virus [PDF]

, 1950
K Penttinen
openalex   +1 more source

Universal influenza vaccines: from viruses to nanoparticles

Expert Review of Vaccines, 2018
Introduction: The current seasonal influenza vaccine confers only limited protection due to waning antibodies or the antigenic shift and drift of major influenza surface antigens. A universal influenza vaccine which induces broad cross-protection against
Ye Wang, Lei Deng, Sang-Moo Kang, Bao-Zhong Wang   +3 more
semanticscholar   +1 more source